Hengrui Pharma Previews ESMO Congress 2026 with 64 Research Findings Across Its Innovative Oncology Portfolio
SHANGHAI, Oct. 20, 2026 /PRNewswire/ — Hengrui Pharma will present 64 research findings at the European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, from October 23 to 27, 2026. These
